Physician

Adam Lawrence Moskowitz, MD

According to 2025 Medicare claims, Adam Moskowitz, MD (NPI: 1679652036) practices gastroenterology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is VANTAGE MEDICAL ASSOCIATES PC (NPI: 1538642996; TIN: 831750325) and primary practice location at 11570-1000. Moskowitz is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), Adirondacks ACO, LLC (ACO ID: A2193), Sunflower ACO LLC (ACO ID: A5499), and Pearl Primary Care Network, LLC (ACO ID: D0242), participating under both the MSSP and REACH models.

Moskowitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 807 HCPCS/CPT codes, and received $51,504 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 298 prescription claims across 124 beneficiaries totaling $29,163 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 12 records totaling $1,380. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $80,678 to $51,504. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,651 and ending at $29,163. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	209	567	$80,678
2016	210	503	$68,759
2017	216	561	$48,914
2018	258	631	$54,065
2019	262	678	$51,400
2020	100	397	$24,349
2021	67	199	$15,144
2022	419	1,473	$121,065
2023	3,829	7,862	$562,493
2024	356	807	$51,504

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	81	$5,651
2016	74	132	$10,715
2017	166	428	$35,416
2018	143	443	$161,824
2019	155	622	$188,709
2020	44	83	$21,330
2021	34	126	$90,187
2022	149	962	$170,325
2023	140	471	$98,122
2024	124	298	$29,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	43	43	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	78	$91
99491	Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month	65	84	$71
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	79	79	$56
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	91	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	23	690	$11,894
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	71	77	$976
Lactulose	Lactulose	12	364	$378
Omeprazole	Omeprazole	38	1,288	$248
Pantoprazole Sodium	Pantoprazole Sodium	21	630	$70

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$1,380	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Lawrence Moskowitz, MD?

Tedicare shows public-source Medicare data for Adam Lawrence Moskowitz, MD (NPI 1679652036), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Lawrence Moskowitz, MD have ACO affiliation data?

Adam Lawrence Moskowitz, MD is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098), Adirondacks ACO, LLC (MSSP, ACO ID A2193), Sunflower ACO LLC (MSSP, ACO ID A5499), and Pearl Primary Care Network, LLC (REACH, ACO ID D0242).

What billing organization is linked to Adam Lawrence Moskowitz, MD?

Adam Lawrence Moskowitz, MD is linked to VANTAGE MEDICAL ASSOCIATES PC (billing NPI 1538642996) in the available physician profile data.

Does Adam Lawrence Moskowitz, MD have Open Payments data?

Adam Lawrence Moskowitz, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.